FI  Werth Family Investment Associates

https://www.werthventures.com/





     Office Locations:

1764 Litchfield Turnpike, Suite 202
Woodbridge, CT 06525

 

Stages:

  • Early
  • Expansion
  • Growth
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 2009 by Peter J. Werth, Werth Family Investment Associates (known as WFIA) is a Family Office focused on venture capital in Woodbridge, Connecticut, that backs the next generation of scientists and entrepreneurs solving the world's toughest healthcare issues. The firm is stage agnostic, investing in seed to late-stage Healthcare companies, across the pharmaceuticals, biotechnology, equipment, distribution, facilities, and managed health care spaces. WFIA has $100M in assets under management. Peter J. Werth is Founder and CEO of ChemWerth Inc., a privately held Connecticut-based corporation founded in 1982. ChemWerth Inc. is a full-service generic drug development and supply company. Along with his family, he has established the Werth Family Foundation to support various philanthropic causes, specifically in educational, cultural, and medical-related causes globally.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Musan Duric Managing Director
    Peter J. Werth CEO
    Vincent P. Asaro CFO

     

    Portfolio companies include:


      Alopexx


      AlzecaBio


      Bastion


      Bright Path


      Cingulate


      Eyenuk


      Likarda


      MedRhythms
        web link


      Nevakar


      Perseus Science Group


      RxSight


      Torigen


      Vera Dermics


     

    Recent News: